Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-30

Clinical Trial Update: Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating melatonin supplementation for cancer-related fatigue in patients with breast cancer undergoing radiotherapy was terminated; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Breast Cancer - Female | Phase 3 | Status: TERMINATED | Results posted: 2023-03-30